Error: Could not add to watchlist. X

S-e-banken Legemiddel

+ Watchlist
SELEGEM:NO
59.56
NOK
0.89
1.48%
As of 02:59:30 ET on 06/30/2015.
Volume
0
Previous Close
60.45
52Wk Range
39.06 - 61.48
1 Yr Return
51.08%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 06/30/2015)
59.5592
Total Assets (m NOK) (on 05/28/2010)
382.750
Inception Date
09/15/1999
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
-
Front Load Fee
-
Back Load Fee
-
Redemption Fee
-
12b-1 Fee
-
Current Mgmt Fee
-
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Roche Holding AG 329.89 k 701.46 m 6.96
Johnson & Johnson 856.85 k 701.41 m 6.96
Gilead Sciences Inc 801.50 k 591.42 m 5.87
Amgen Inc 444.53 k 554.32 m 5.50
Pfizer Inc 2.12 m 517.48 m 5.13
AbbVie Inc 1.01 m 515.36 m 5.11
Shire PLC 699.24 k 386.89 m 3.84
HCA Holdings Inc 599.90 k 344.65 m 3.42
Universal Health Services Inc 379.10 k 330.18 m 3.28
Cigna Corp 401.40 k 323.37 m 3.21
Profile
SEB Legemiddel Fund is an open-end fund incorporated in Sweden. The Fund invests primarily in equities and equity related securities of major pharmaceutical, medical technology, biotechnology and medical services companies.
ADDRESS
SEB SE
P.B 1843 Vika
N-0123 Oslo
Norway
PHONE
47-810-01-050